These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20926616)

  • 1. Physiological basis for inhibition of morphine and improgan antinociception by CC12, a P450 epoxygenase inhibitor.
    Heinricher MM; Maire JJ; Lee D; Nalwalk JW; Hough LB
    J Neurophysiol; 2010 Dec; 104(6):3222-30. PubMed ID: 20926616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic.
    Hough LB; Nalwalk JW; Yang J; Conroy JL; VanAlstine MA; Yang W; Gargano J; Shan Z; Zhang SZ; Wentland MP; Phillips JG; Knapp BI; Bidlack JM; Zuiderveld OP; Leurs R; Ding X
    Pain; 2011 Apr; 152(4):878-887. PubMed ID: 21316152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception.
    Conroy JL; Nalwalk JW; Phillips JG; Hough LB
    Brain Res; 2013 Mar; 1499():1-11. PubMed ID: 23298831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural basis for improgan antinociception.
    Heinricher MM; Martenson ME; Nalwalk JW; Hough LB
    Neuroscience; 2010 Sep; 169(3):1414-20. PubMed ID: 20570607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.
    Hough LB; Nalwalk JW; Phillips JG; Kern B; Shan Z; Wentland MP; de Esch IJ; Janssen E; Barr T; Stadel R
    Neuropharmacology; 2007 Apr; 52(5):1244-55. PubMed ID: 17336343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improgan-induced hypothermia: a role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature.
    Salussolia CL; Nalwalk JW; Hough LB
    Brain Res; 2007 Jun; 1152():42-8. PubMed ID: 17433267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain-facilitating medullary neurons contribute to opioid-induced respiratory depression.
    Phillips RS; Cleary DR; Nalwalk JW; Arttamangkul S; Hough LB; Heinricher MM
    J Neurophysiol; 2012 Nov; 108(9):2393-404. PubMed ID: 22956800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception.
    Meng ID; Johansen JP; Harasawa I; Fields HL
    J Neurophysiol; 2005 Mar; 93(3):1138-44. PubMed ID: 15456805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist.
    Meng ID; Johansen JP
    Neuroscience; 2004; 124(3):685-93. PubMed ID: 14980738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.
    Heinricher MM; McGaraughty S; Tortorici V
    J Neurophysiol; 2001 Jan; 85(1):280-6. PubMed ID: 11152727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity.
    McGaraughty S; Heinricher MM
    Pain; 2002 Mar; 96(1-2):153-62. PubMed ID: 11932071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine.
    Heinricher MM; McGaraughty S; Farr DA
    Pain; 1999 May; 81(1-2):57-65. PubMed ID: 10353493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically.
    Heinricher MM; Schouten JC; Jobst EE
    Pain; 2001 May; 92(1-2):129-38. PubMed ID: 11323134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.
    Heinricher MM; McGaraughty S; Grandy DK
    J Neurophysiol; 1997 Dec; 78(6):3351-8. PubMed ID: 9405549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive activity of CC44, a biotinylated improgan congener.
    Hoerbelt P; Nalwalk JW; Phillips JG; Wentland MP; Shan Z; Hough LB
    Eur J Pharmacol; 2013 Aug; 714(1-3):464-71. PubMed ID: 23834775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic.
    Svokos K; Nalwalk JW; Leurs R; Menge WM; Timmerman H; Hough LB
    Brain Res; 2001 Dec; 923(1-2):12-9. PubMed ID: 11743967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla.
    Heinricher MM; Morgan MM; Tortorici V; Fields HL
    Neuroscience; 1994 Nov; 63(1):279-88. PubMed ID: 7898652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of improgan, a non-opioid analgesic, in neuropathic pain.
    Albrecht PJ; Nalwalk JW; Hough LB
    Brain Res; 2011 Nov; 1424():32-7. PubMed ID: 22015352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic.
    Hough LB; de Esch IJ; Janssen E; Phillips J; Svokos K; Kern B; Trachler J; Abood ME; Leurs R; Nalwalk JW
    Neuropharmacology; 2006 Sep; 51(3):447-56. PubMed ID: 16806300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.